DOREST EYE DROPS

TARGETED CONTROL OF EYE PRESSURE

DOREST

Dorzolamide Hydrochloride IP 2% w/v Eye Drops / 5ml

TOPICAL CARBONIC ANHYDRASE INHIBITOR

• IOP Reduction reduces intraocular pressure by effectively decreasing the production of aqueous humor.
• Non-Beta Blocker is an option of critical therapy to patients who are unable to use beta-blocker eye drops.
• Localized Action does not produce any systemic side effects and therefore is safe to use in the long term due to its local action on the eye.
• Versatile Use suitable as both a standalone monotherapy or as an adjunct therapy in complex glaucoma cases.
• Indications: Open-angle glaucoma, Ocular hypertension, and long-term IOP control.